Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
6%
OVERLAP
BY WEIGHT
4
# OF OVERLAPPING
HOLDINGS
HART
69
HOLDINGS
7%
ALSO IN XPH
XPH
60
HOLDINGS
7%
ALSO IN HART
SECTOR DRIFT (HART minus XPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HART |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
BRISTOL-MYERS SQUIBB CO | 3.6% | 1.6% | 1.6% |
|
JOHNSON & JOHNSON | 7.5% | 1.6% | 1.6% |
|
ELI LILLY & CO | 7.5% | 1.6% | 1.6% |
|
PFIZER INC | 5.4% | 1.5% | 1.5% |
HART Overweight Relative to XPH
|
APPLE INC | 7.5% |
|
UNITEDHEALTH GROUP INC | 6.7% |
 |
NOVARTIS AG | 6.5% |
 |
ASTRAZENECA PLC | 6.1% |
|
ELI LILLY & CO | 6.0% |
|
JOHNSON & JOHNSON | 5.9% |
|
ALPHABET INC. CLASS A | 5.8% |
|
PFIZER INC | 4.0% |
 |
MEDTRONIC PLC | 3.4% |
|
ABBOTT LABORATORIES | 3.4% |
HART Underweight Relative to XPH
|
CRINETICS PHARMACEUTICALS INC | -3.7% |
|
MBX BIOSCIENCES INC | -3.1% |
|
DEFINIUM THERAPEUTICS INC | -2.9% |
|
ENLIVEN THERAPEUTICS, INC. | -2.2% |
|
ALUMIS INC | -2.1% |
|
TREVI THERAPEUTICS, INC. | -2.1% |
|
AMYLYX PHARMACEUTICALS, INC. | -2.0% |
|
HARROW INC | -2.0% |
|
NUVATION BIO INC CLASS A | -1.9% |
|
LIQUIDIA TECHNOLOGIES, INC. | -1.8% |